Harbor Investment Advisory’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24
Closed -$1.96K 1353
2023
Q1
$1.96K Hold
24
﹤0.01% 1222
2022
Q4
$2.03K Hold
24
﹤0.01% 1201
2022
Q3
$2K Hold
24
﹤0.01% 1222
2022
Q2
$3K Hold
24
﹤0.01% 1195
2022
Q1
$3K Hold
24
﹤0.01% 1211
2021
Q4
$6K Hold
24
﹤0.01% 1120
2021
Q3
$6K Hold
24
﹤0.01% 1125
2021
Q2
$10K Hold
24
﹤0.01% 1016
2021
Q1
$9K Hold
24
﹤0.01% 1004
2020
Q4
$7K Hold
24
﹤0.01% 972
2020
Q3
$8K Hold
24
﹤0.01% 880
2020
Q2
$3K Hold
24
﹤0.01% 924
2020
Q1
$3K Hold
24
﹤0.01% 895
2019
Q4
$3K Buy
+24
New +$2.65K ﹤0.01% 747

Other funds holding DRIO

Harbor Investment Advisory's DRIO Position: Q2 2023 in Review

Harbor Investment Advisory sold out of DarioHealth (DRIO) in Q2 2023, closing a stake of 24 shares — an estimated $1.96K sold.

Harbor Investment Advisory first reported a position in DRIO in Q4 2019 and held it in 14 quarters. The position peaked at $10K in Q2 2021. 45 funds tracked by Wall St. Rank hold DRIO as of Q2 2023.

  • Harbor Investment Advisory reported no remaining DarioHealth position as of Q2 2023 after selling out during the quarter.
  • Harbor Investment Advisory sold 24 DarioHealth shares in Q2 2023, an estimated $1.96K.
  • Harbor Investment Advisory first reported a position in DarioHealth in Q4 2019 and held it in 14 quarters.
  • Harbor Investment Advisory's DarioHealth position peaked at $10K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held DarioHealth as of Q2 2023.

Based on Harbor Investment Advisory's 13F filing for Q2 2023, filed 14 Jul 2023.